Literature DB >> 8239580

Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.

H Yasuda1, Y Ajiki, T Koga, H Kawada, T Yokota.   

Abstract

Interactions between bacterial biofilms formed by Pseudomonas aeruginosa and clarithromycin, a macrolide having no anti-P. aeruginosa activity, were investigated. P. aeruginosa incubated for 10 days on membrane filters formed biofilms on the surfaces of the filters. The biofilms were characterized by dense colonizations of bacteria and thick membranous structures that covered the colonies. Treatment of the biofilms with a relatively low concentration of clarithromycin for 5 days resulted in an eradication of the membranous structures. Quantitative analysis of alginate and hexose was done to evaluate the quantity of polysaccharides in or on the biofilms. Treatment of the biofilms with clarithromycin decreased the quantity of alginate and hexose and therefore perhaps the quantity of polysaccharides as well. Eradication of the membranous structures of biofilms, or the decrease in the quantity of polysaccharides, resulted in an increase in the rate of penetration of antibiotics through bacterial biofilms. In vivo therapeutic effects of ofloxacin in the rat infection model, in which the biofilm mode of growth of P. aeruginosa is characteristic, were enhanced by oral coadministration of clarithromycin. It is suggested that clarithromycin eradicated glycocalyx produced by P. aeruginosa, or suppressed the production of glycocalyx, by unknown mechanisms and thereby enhanced the therapeutic efficacies of other antimicrobial agents against infections caused by P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239580      PMCID: PMC188065          DOI: 10.1128/AAC.37.9.1749

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  The determination of sugar in blood and spinal fluid with anthrone reagent.

Authors:  J H ROE
Journal:  J Biol Chem       Date:  1955-01       Impact factor: 5.157

Review 2.  Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices.

Authors:  G M Dickinson; A L Bisno
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 3.  Resistance of bacterial biofilms to antibiotics: a growth-rate related effect?

Authors:  M R Brown; D G Allison; P Gilbert
Journal:  J Antimicrob Chemother       Date:  1988-12       Impact factor: 5.790

4.  Adhesive colonization of biomaterials and antibiotic resistance.

Authors:  A G Gristina; C D Hobgood; L X Webb; Q N Myrvik
Journal:  Biomaterials       Date:  1987-11       Impact factor: 12.479

5.  Method of evaluating effects of antibiotics on bacterial biofilm.

Authors:  B L Prosser; D Taylor; B A Dix; R Cleeland
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci.

Authors:  L Dall; W G Barnes; J W Lane; J Mills
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

7.  A new polysaccharide resembling alginic acid isolated from pseudomonads.

Authors:  A Linker; R S Jones
Journal:  J Biol Chem       Date:  1966-08-25       Impact factor: 5.157

Review 8.  Synergy of fluoroquinolones with other antimicrobial agents.

Authors:  H C Neu
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

9.  Interference with granulocyte function by Staphylococcus epidermidis slime.

Authors:  G M Johnson; D A Lee; W E Regelmann; E D Gray; G Peters; P G Quie
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

10.  Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.

Authors:  L R Evans; A Linker
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

View more
  32 in total

1.  In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia.

Authors:  A Giacometti; O Cirioni; M S Del Prete; F Barchiesi; M Fortuna; D Drenaggi; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?

Authors:  Cristina El Haj; Oscar Murillo; Alba Ribera; Dolors Garcia-Somoza; Fe Tubau; Carmen Cabellos; Javier Cabo; Javier Ariza
Journal:  Med Microbiol Immunol       Date:  2016-09-17       Impact factor: 3.402

Review 3.  Erythromycin and diffuse panbronchiolitis.

Authors:  H Koyama; D M Geddes
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

Review 4.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

5.  Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.

Authors:  J N Anderl; M J Franklin; P S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 6.  Antibiofilm agents: A new perspective for antimicrobial strategy.

Authors:  Xi-Hui Li; Joon-Hee Lee
Journal:  J Microbiol       Date:  2017-09-28       Impact factor: 3.422

Review 7.  Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions.

Authors:  Sarah E Rowe; Jenna E Beam; Brian P Conlon
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

8.  Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors.

Authors:  Mai Alhajlan; Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

9.  Nosocomial septicemias due to methicillin-resistant staphylococcus aureus and Pseudomonas aeruginosa in a university hospital over a 12-year period--the same intractable infections.

Authors:  Y Mizushima; H Li; I Yoshida; K Sassa; T Hamazaki; M Kobayashi
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

10.  Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin.

Authors:  Marshall C Walters; Frank Roe; Amandine Bugnicourt; Michael J Franklin; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.